By Jeanne Whalen
The Wall Street Journal Europe
23 May 2007
CONCERNS about the safety of GlaxoSmithKline PLC’s diabetes drug Avandia underscore the different approaches to medical regulation in different markets. A day after U.S. politicians called on the U.S. Food and Drug Administration to strengthen its... read more...
posted by Bank Report at
4:28 PM
0 Comments:
Post a Comment
<< Home